|
PIK3C2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.454400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.657200E-01 |
| Normal-vs-Stage2 |
9.055000E-01 |
| Normal-vs-Stage3 |
4.354800E-01 |
| Normal-vs-Stage4 |
3.440600E-01 |
| Stage1-vs-Stage2 |
5.821400E-01 |
| Stage1-vs-Stage3 |
1.092550E-01 |
| Stage1-vs-Stage4 |
8.064400E-01 |
| Stage2-vs-Stage3 |
4.803800E-01 |
| Stage2-vs-Stage4 |
5.320400E-01 |
| Stage3-vs-Stage4 |
2.911200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.308400E-01 |
| Normal-vs-AfricanAmerican |
6.538400E-01 |
| Normal-vs-Asian |
4.707000E-01 |
| Caucasian-vs-AfricanAmerican |
9.376800E-01 |
| Caucasian-vs-Asian |
5.681400E-01 |
| AfricanAmerican-vs-Asian |
4.284200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.857900E-02 |
| Normal-vs-Female |
2.008100E-02 |
| Male-vs-Female |
4.019900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.680800E-01 |
| Normal-vs-Extreme_Weight |
8.964100E-02 |
| Normal-vs-Obese |
6.297200E-01 |
| Normal-vs-Extreme_Obese |
3.159200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.319810E-01 |
| Normal_Weight-vs-Obese |
5.863200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.898000E-01 |
| Extreme_Weight-vs-Obese |
2.611600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.296600E-01 |
| Obese-vs-Extreme_Obese |
6.216600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.169800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.114400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.534600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.553100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.304000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.120800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.183900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.934400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.193600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.459100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.384400E-01 |
| Normal-VS-Type2 PRCC |
1.318040E-01 |
| Normal-VS-KIRP CIMP |
1.187430E-01 |
| Normal-VS-Unclassified PRCC |
4.436000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.458440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.676300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.327200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.242120E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.708600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.634400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.390400E-01 |
| Normal-vs-N1 |
6.588000E-01 |
| Normal-vs-N2 |
9.881400E-01 |
| N0-vs-N1 |
2.617800E-01 |
| N0-vs-N2 |
7.408000E-01 |
| N1-vs-N2 |
8.472800E-01 |
|
|
